Mechanoresponsive reprogramming of tumor-associated macrophages during cancer progression
3D tumor models and organ-on-a-chip systems may reveal how physical forces steer macrophages toward tumor-supportive states.
2026-10-04
Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis
A spiral microfluidic chip and AI identified rare tumor cells in artificial blood without antibody labels.
2026-10-02
AI Chip Helps Find Rare Cancer Cells in Blood in New Liquid Biopsy Study
A spiral microfluidic chip and AI model enriched and identified rare tumor cells in laboratory blood samples.
2026-10-01
New cell-collection device could improve early cancer detection
MIT's handheld microfluidic device gently collects viable cells from targeted tissue sites without disrupting pathology samples.
2026-10-01
AI-Enhanced Microfluidic Chip Enables Label-Free Detection of Circulating Tumor Cells
A microfluidic chip and AI detected tumor cells in artificial blood samples without fluorescent labels.
2026-10-01
AI Chip Helps Find Rare Cancer Cells in Blood in New Liquid Biopsy Study
A spiral microfluidic chip and image AI found rare tumor cells in laboratory blood samples without final-step fluorescent staining.
2026-10-01
AI-Enhanced Photonic Biosensor Could Help Detect Glioblastoma Tissue
A simulated photonic crystal sensor used light and AI to distinguish modeled glioblastoma tissue from nearby brain tissue.
2026-10-01
Engineered Allosteric Biosensor for In Situ DNA Glycosylase Detection in Neuroblastoma Risk Stratification and Drug Resistance Monitoring
A DNA nanostructure sensor tracks a DNA repair enzyme tied to neuroblastoma risk and treatment resistance.
2026-09-30
Quantum Nanosensors Could Reveal What Organs-on-Chips Miss
Quantum sensors could help organ-on-a-chip devices track fleeting cellular signals in real time.
2026-09-23
TissueGnostics collaborates with Diya Biological Technology in organoid and organ-on-a-chip innovation
TissueGnostics and Diya Biological Technology link spatial imaging with organoid and organ-on-a-chip research services.
2026-09-18
Syntopia
Syntopia combines microfluidic systems, perfused human tissue cultures and computational models to study drug responses. Its platform generates spatial and temporal measurements from three-dimensional models, with a focus on evaluating antibody-drug conjugates before clinical testing.
2026-09-14
AIM Biotech
AIM Biotech develops microfluidic platforms for three-dimensional human cell cultures. Its chip and plate systems support studies of tissue interactions in cancer, vascular biology and neurobiology, alongside research services that apply these models to drug discovery.
2026-09-14